Rebecca Redman
- Epidemiology top 2%
- Critical Care and Intensive Care Medicine top 0.2%
- Pulmonary and Respiratory Medicine top 5%
- Hepatology top 1%
- Oncology top 5%
- Co-authors
- Marin H. KollefLisa A. BellmMontserrat Vera‐LlonchJordi RelloGerry OsterDaniel A. OllendorfEdward TamKoné Kaniga
- Topics
- Head and Neck Cancer Studies (18 papers)Hepatitis C virus research (18 papers)Antibiotics Pharmacokinetics and Efficacy (16 papers)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Rebecca Redman
95 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Epidemiology 1.4k
- Critical Care and Intensive Care Medicine 906
- Pulmonary and Respiratory Medicine 690
- Hepatology 674
- Oncology 548
Countries citing papers authored by Rebecca Redman
This map shows the geographic impact of Rebecca Redman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Redman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Redman more than expected).
Fields of papers citing papers by Rebecca Redman
This network shows the impact of papers produced by Rebecca Redman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Redman. The network helps show where Rebecca Redman may publish in the future.
Co-authorship network of co-authors of Rebecca Redman
This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Redman. A scholar is included among the top collaborators of Rebecca Redman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Redman. Rebecca Redman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 studybreakdown → | 258 |
| 5 | 9 | |
| 6 | 13 | |
| 7 | 1 | |
| 8 | 41 | |
| 9 | 3 | |
| 10 | 8 | |
| 11 | 2 | |
| 12 | 11 | |
| 13 | 68 | |
| 14 | 5 | |
| 15 | 18 | |
| 16 | 42 | |
| 17 | 17 | |
| 18 | 108 | |
| 19 | Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Databasebreakdown → | 959 |
| 20 | 94 |
About Rebecca Redman
Rebecca Redman is a scholar working on Otorhinolaryngology, Hepatology and Pharmacology, having authored 97 papers that have together received 3.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (18 papers), Hepatitis C virus research (18 papers) and Antibiotics Pharmacokinetics and Efficacy (16 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (906 citations), Applied Microbiology and Biotechnology (185 citations) and Hepatology (674 citations). Rebecca Redman has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Marin H. Kollef, Lisa A. Bellm, Montserrat Vera‐Llonch, Jordi Rello, Gerry Oster, Daniel A. Ollendorf, Edward Tam, Koné Kaniga, Gilles Tapolsky and Jason Chesney. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.